Recalls of prescription drugs, over-the-counter medications, and compounded pharmaceuticals.
Showing 941–960 of 17,683 recalls
Breckenridge Pharmaceutical, Inc.
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.
Breckenridge Pharmaceutical, Inc.
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.